Correlation Engine 2.0
Clear Search sequence regions


  • AC 3 (1)
  • ACG (5)
  • activated hepatic stellate cells (13)
  • ADRP (13)
  • AGC (4)
  • analysis data (1)
  • antibodies (2)
  • apoptosis (1)
  • ATC (4)
  • ATP6V1C1 (35)
  • carbon (1)
  • cat (3)
  • ccc (4)
  • CCl4 (15)
  • cdna (1)
  • cell cycle (1)
  • Col1 (5)
  • collagen (2)
  • collagen type i (1)
  • control groups (1)
  • culture cell (1)
  • cytokines (1)
  • drug treatment (1)
  • dye (1)
  • electrophoresis (1)
  • essential (1)
  • expressed genes (2)
  • extracellular matrix (4)
  • factors (13)
  • fat cells (1)
  • fibrosis renal (2)
  • g subunits (1)
  • GA 3 (2)
  • gaa (3)
  • GAPDH (6)
  • GAT 3 (1)
  • GCA (6)
  • gene plants (1)
  • genes C (1)
  • GGA (4)
  • GGC (5)
  • glomerulosclerosis (1)
  • glycerol (1)
  • GTG (3)
  • hepatocellular carcinoma (1)
  • HSC (18)
  • human (6)
  • human cell (4)
  • isopropanol (2)
  • knockout mice (1)
  • lipid (11)
  • lipogenesis (2)
  • liver (13)
  • liver fibrosis (30)
  • lung fibrosis (1)
  • mice (10)
  • micrornas (2)
  • MIR29a (45)
  • MIR29c (1)
  • mortality (1)
  • mrna (5)
  • myelofibrosis (1)
  • myoblasts (1)
  • myofibroblasts (3)
  • normal liver (1)
  • nucleotides (1)
  • oil (2)
  • oil red o (5)
  • patients (3)
  • pcr (4)
  • penicillin (1)
  • phosphate (2)
  • protein knockdown (1)
  • protein levels (2)
  • protocol (1)
  • pvdf (1)
  • quiescent hepatic stellate cells (5)
  • random (1)
  • reagents (2)
  • retinoids (2)
  • rna (4)
  • serum (1)
  • sirna (12)
  • skeletal muscle (1)
  • Srebp 1c (8)
  • stain (1)
  • sterol (1)
  • streptomycin (1)
  • student (1)
  • suggest (2)
  • TC 3 (2)
  • TCA 3 (1)
  • TCC (5)
  • TGA (3)
  • TGT (3)
  • trizol (1)
  • volunteers (1)
  • western blot (1)
  • Sizes of these terms reflect their relevance to your search.

    Activated hepatic stellate cells (aHSCs) play a key role in liver fibrosis. During the regression of fibrosis, aHSCs are transformed into inactivated cells (iHSCs), which are quiescent lipid-containing cells and express higher levels of lipid-related genes, such as peroxisome proliferators-activated receptors gamma (PPARγ). Here, we investigated the role of MicroRNA29a (Mir29a) in the resolution of liver fibrosis. Mir29a and lipid-related genes were up-regulated after the recovery of CCl4-induced liver fibrosis in mice. PPARγ agonist rosiglitazone (RSG) promoted de-differentiation of aHSCs to iHSCs and up-regulated MIR29a expression in a human HSC cell line LX-2. MIR29a mimics in vitro promoted the expression of lipid-related genes, while decreased the expression of fibrosis-related genes. MIR29a inhibitor showed the reverse effects. ATPase H+ transporting V1 subunit C1 (Atp6v1c1) was increased in liver fibrosis, while down-regulated after the recovery in mice, and negatively regulated by MIR29a in LX-2 cells. Knockdown of ATP6V1C1 by siRNA decreased alpha-smooth muscle actin (α-SMA) and increased lipid-related genes expression. Simultaneous addition of MIR29a mimics and ATP6V1C1 siRNA further increased RSG promoted expression of lipid-related proteins in vitro. Collectively, MIR29a plays an important role during the trans-differentiation of aHSCs in the resolution of liver fibrosis, in part, through regulation of ATP6V1C1.

    Citation

    Fei Jing, Yan Geng, Xin-Yi Xu, Hong-Yu Xu, Jin-Song Shi, Zheng-Hong Xu. MicroRNA29a Reverts the Activated Hepatic Stellate Cells in the Regression of Hepatic Fibrosis through Regulation of ATPase H+ Transporting V1 Subunit C1 International Journal of Molecular Sciences. 2019 Feb 13;20(4)


    PMID: 30781750

    View Full Text